DHL Supply Chain launches new pharma hub in Singapore

DHL Supply Chain launched a new pharma hub in Singapore, a dedicated facility for pharmaceutical logistics.

The €10 million facility is part of DHL Group’s €500 million investment into Asia Pacific to bolster its life sciences and healthcare (LSHC) infrastructure across all business units, says an official release.

"At DHL Supply Chain, we are committed to supporting the rapidly growing LSHC sector in Asia Pacific where there is a growing demand for transformative healthcare solutions due to longer lifespans, personalized treatments and rising consumer expectations," says Javier Bilbao, CEO, DHL Supply Chain Asia Pacific. "By 2030, the region’s medical market is projected to reach $138 billion (~€127 billion), reflecting the critical need for resilient and efficient supply chains. As part of DHL Group’s Strategy 2030, we have invested ahead to strengthen our infrastructure and capabilities, ensuring we can meet the evolving and increasingly complex needs of our customers.

"Our investment goes beyond building warehouses or expanding networks. It is about building a foundation across all our business units that enables faster, more reliable delivery of life-saving medicines and healthcare products. In a region where healthcare demand is surging, we enable our customers to focus on innovation and patient care. At the same time, we handle the complexities of supply chain management across all logistics touchpoints - from storage, order fulfillment, and distribution to global shipping and last-mile delivery. This is how we deliver real value: by turning challenges into opportunities and ensuring that every link in the healthcare supply chain works seamlessly."

The new 8,200 square meters pharma hub at 8 Jurong Pier in Singapore features specialised temperature-controlled zones including ambient (15°C to 25°C) and cold room (2°C to 8°C), ensuring precise storage conditions for sensitive healthcare products, the release added.

"Located near Tuas Bio-Medical Park, the pharma hub offers seamless connectivity to Changi Airport and Tuas Mega Port, enabling efficient regional and global distribution for pharmaceutical partners."

Eunis Hew, Managing Director, DHL Supply Chain Singapore says: "Singapore is laser-focused on becoming a global leader in life sciences and medtech innovation. The country’s ambitions are backed by investments, such as a top-up of SGD$3 billion (~€2 billion) in Budget 2025 to attract investments in sectors like semiconductors and life sciences, as well as other key initiatives, including the National Research, Innovation and Enterprise (RIE).